Role of HLA in hematopoietic SCT

HLA disparity between hematopoietic stem cell (HSC) donor and recipient triggers T-cell and NK-cell allorecognition, and induces the GVHD, GVL effect and/or may cause an engraftment failure. This review will cover the scope of human genomic variation, the methods of HLA typing and interpretation of high-resolution HLA results. We describe the main subsets of related and unrelated HSC donors and outline the main aspects of HLA disparity and their effect on the outcome of the patients after allogeneic HSC transplantation (HSCT). The HLA match between HSCT donor and recipient is crucial, but for many patients a perfectly matched donor is not available. The HSCT from the alternative mismatched donor with one allele/antigen mismatch (9/10) can be as beneficial as a HSCT from a fully matched donor, especially in younger patients. For the remaining patients, the donors with permissive mismatches may be the option. The permissiveness depends not only on the potential adverse effect of the HLA mismatches, but also on the urgency of the transplantation, the desirable GVL effect and the potential efficacy of the alternative therapy available for the patient.

[1]  J. Nowak,et al.  Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. , 2008, Tissue antigens.

[2]  Harriet Noreen,et al.  Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. , 2007, Human immunology.

[3]  J. Mehta,et al.  Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation , 2007, Bone Marrow Transplantation.

[4]  X. Yang,et al.  Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant , 2007, Bone Marrow Transplantation.

[5]  R. Handgretinger,et al.  T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantation , 2003, British journal of haematology.

[6]  H. Heslop,et al.  Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[7]  C. Schmoor,et al.  Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  G. Church,et al.  A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression , 2000, Nature Genetics.

[9]  D Middleton,et al.  New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.

[10]  E. Shpall,et al.  Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies , 2007, Bone Marrow Transplantation.

[11]  J. Ritz,et al.  Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. , 2007, Blood.

[12]  M. Sykes.  Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors , 2022 .

[13]  E. Mejstrikova,et al.  Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen‐mismatched unrelated donors , 2008, Pediatric transplantation.

[14]  M. Malkki,et al.  Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. , 2007, Tissue antigens.

[15]  A. Tichelli,et al.  Recent improvement in outcome of unrelated donor transplantation for aplastic anemia , 2008, Bone Marrow Transplantation.

[16]  Derek Middleton,et al.  A new allele frequency database , 2002 .

[17]  Shunichi Kato,et al.  High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. , 2007, Blood.

[18]  H. Greinix,et al.  Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors , 2005, Bone Marrow Transplantation.

[19]  G. Salles,et al.  Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. , 2007, Tissue antigens.

[20]  J. Bourhis,et al.  Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Gobbi,et al.  Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant , 2007, Bone Marrow Transplantation.

[22]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[23]  Y. Lau,et al.  Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[24]  M. Labopin,et al.  Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation , 2007, Bone Marrow Transplantation.

[25]  M. Horowitz,et al.  Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. , 2007, Tissue antigens.

[26]  D. Roelen,et al.  Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[27]  A. Begovich,et al.  A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. , 2007, Human immunology.

[28]  Franco Locatelli,et al.  Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.

[29]  A. Gratwohl,et al.  The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable , 2007, Bone Marrow Transplantation.

[30]  C. Craddock,et al.  The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. , 2004, Blood.

[31]  L. Price,et al.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality , 2006, Bone Marrow Transplantation.